Financial Result for Quarter and half year ended 30th September, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ambar Protein Industries reported its Q2 FY26 and H1 FY26 unaudited results approved by the Board on October 17, 2025. Total income for Q2 came in at ₹11,314.95 lakhs, down about 3.7% from ₹11,746.31 lakhs in Q2 FY25. For the half year, revenue fell roughly 13% to ₹19,917.40 lakhs versus ₹22,893.66 lakhs last year. Profit after tax slipped to ₹200.06 lakhs in Q2 (from ₹220.15 lakhs) and to ₹269.77 lakhs for H1 (from ₹335.93 lakhs), with H1 EPS at ₹4.69 versus ₹5.84. The auditor (Fenil P. Shah and Associates) issued an unqualified limited review report with no concerns flagged.
Both revenue and profits are shrinking year-on-year, signalling weak operating performance. Shareholders should note the continued decline in top line and earnings, though the balance sheet still shows equity of ₹3,747.64 lakhs against current borrowings of ₹2,286 lakhs.